Article
Multiple myeloma and chronic lymphocytic leukemia.
Current opinion in hematology - 1 Jul 1995
Rosen L, Vescio R, Berenson J R
Abstract excerpt
New insights into the molecular biology of both multiple myeloma and chronic lymphocytic leukemia can potentially lead to new treatment modalities. For myeloma, its lack of CD34 expression can lead to a functional but less contaminated autograft for stem cell transplantation. Single or even double transplants are being used to treat high-risk or even relapsed disease. Cytokines, such as interleukin-6, appear to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
